Signaling pathways and diabetic embryopathy

Seminars in Reproductive Endocrinology

Volumn 17, Issue 2, 1999, Pages 167-174

  Dhanasekaran, N ^a   Wu, Ying King ^a   Albert Reece, E ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Arachidonic Acid; COX 2; Diabetic embryopathy; ERK; Hypoglycemia; JNK; p38MAPK; PKC; PLA2; Prostaglandins; ROS

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; PHOSPHATIDYLINOSITOL KINASE; PHOSPHOLIPASE A2; PROTEIN KINASE B; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; SYNAPTOPHYSIN;

ARACHIDONIC ACID METABOLISM; EMBRYO; EMBRYO DEVELOPMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT DISEASE; MATERNAL DIABETES MELLITUS; PERINATAL DEVELOPMENT; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032884974     PISSN: 07348630     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1016223     Document Type: Review

References (62)

1. Kucera J. Rate and type of congenital anomalies among offspring of diabetic women. J Reprod Med 1971;7:61-70
2. Mills JL, Baker L, Goldman AS. Malformations in infants of diabetic mothers occur before the seventh gestational week: Implications for treatment. Diabetes 1979;28:292-293
3. Mills JL. Malformations in infants of diabetic mothers. Teratology 1982;25:385-394
4. Naftolin F, Diamond MP, Pinter E, Reece EA, Sanyal MK. A hypothesis concerning the general basis of organogenic congenital anomalies. Am J Obstet Gynecol 1987;157:1-4
5. Reece EA, Pinter E, Homko C, Wu Y-K, Naftolin F. The yolk sac theory: Closing the circle on why diabetes-associated malformations occur. J Soc Gynecol Invest 1994;1:3-13
6. Reece EA, Wu Y-K. Multifactoral basis of the syndrome of diabetic embryopathy. Teratology 1996;54:171-182
7. Hod M. Advances in understanding of diabetic embryopathy: Signal transduction. Early Preg Biol Med 1996;2:121-128
8. Pinter E, Reece EA, Leranth CZ, et al. Arachidonic acid prevents hyperglycemia-associated yolk sac damage and embryopathy. Am J Obstet Gynecol 1986;155:691-702
9. Pinter E, Reece EA, Ogburn PL Jr, et al. Fatty acid content of yolk sac and embryo in hyperglycemia-induced embryopathy and effect of arachidonic acid supplementation. Am J Obstet Gynecol 1988;159:1484-1490
10. 2 prevents anomalies induced by hyperglycemia of diabetic serum in mouse embryos. Diabetes 1992;41:1644-1650
11. 2 levels in mouse embryos during neurulation. Diabetologia 1996;39:915-920
12. Baker L, Piddington R, Goldman A, Egler J, Moehring J. Myoinositol and prostaglandins reverse the glucose inhibition of neural tube fusion in cultured mouse embryos. Diabetologia 1990;33:593-596
13. Reece EA, Khandelwel M, Wu Y-K, Borenstein M. Dietary intake of myo-inositol and neural tube defects in offspring defects in offspring of diabetic rats. Am J Obstet Gynecol 1997;176:536-539
14. Sivan E, Reece EA, Wu Y-K, Homko CJ, Polansky M, Borenstein M. Dietary vitamin E prophylaxis and diabetic embryopathy: Morphologic and biochemical analysis. Am J Obstet Gynecol 1996;175:793-796
15. Reece EA, Wu Y-K. Prevention of diabetic embryopathy in offspring of diabetic rats with use of cocktail of deficient substrates and an antioxidant. Am J Obstet Gynecol 1997;176:790-798
16. Reece EA, Wu Y-K, Wiznitzer A, et al. Dietary polyunsaturated fatty acid prevents malformations in offspring of diabetic rats. Am J Obstet Gynecol 1996;175:818-823
17. Cousins L. Congenital anomalies among infants of diabetic mothers: Etiology, prevention, prenatal diagnosis. Am J Obstet Gynecol 1983;147:333-338
18. Becerra JE, Khoury MJ, Cordero JF, Erckson JD. Diabetes mellitus during pregnancy and the risks for the specific birth defects: A population based case control study. Pediatrics 1990;85:1-9
19. Pinter E, Reece EA, Leranth CZ, et al. Yolk sac failure in embryopathy due to hyperglycemia: Ultrastructural analysis of yolk sac differentiation in rat conceptuses under hyperglycemic conditions. Teratology 1986;33:73-84
20. Reece EA, Pinter E, Leranth CZ, et al. Ultrastructural analysis of malformations of the embryonic neural axis induced by in vitro hyperglycemic conditions. Teratology 1986;32:363-373
21. Hunter ESI, Sadler TW. Fuel mediated teratogenesis: Biochemical effects of hypoglycemia during neurulation in mouse embryos in vitro. Am J Physiol 1989;257:E269-E276
22. Martinez-Friaz ML. Epidemiological analysis of outcomes of pregnancy in diabetic mothers: Identification of the most characteristic and most frequent congenital anomalies. Am J Med Genet 1994;51:108-113
23. Van Allen MI, Brown ZA, Plovie B, Hanson ML, Knopp RH. Deformations in infants of diabetic and control pregnancies. Am J Med Genet 1994;53:210-215
24. DuBois RN, Abramson SB, Crofford L, et al. Cyclooxygenases in biology and disease. FASEB J 1998;12:1063-1073
25. Natarajan R, Lanting L, Gonzales N, Nadler J. Formation of an F2-isoprostane in vascular smooth muscle cells by elevated glucose and growth factors. Am J Physiol 1996;271: H151-H165
26. Eriksson UJ. The antioxidants Trolox and N-acetyl-cysteine protect rat embryos from the teratogenic effects of a diabetic environment in vitro. Diabetes 1994;43(Suppl 1):136A
27. Hagay ZJ, Weiss Y, Zusman I, et al. Prevention of diabetes-associated embryopathy by overexpression of the free radical scavenger copper zinc superoxide dismutase in transgenic mouse embryos. Am J Obstet Gynecol 1995;173:1036-1041
28. 2 levels in rat embryos exposed to a diabetic environment. Diabetes 1999;48:813-820
29. Goldman AS, Baker L, Piddington R, Marx B, Herold R, Egler J. Hyperglycemia-induced teratogenesis is mediated by a functional deficiency of arachidonic acid. Proc Natl Acad Sci USA 1985;82:8227-8231
30. Reece EA, Pinter E, Leranth C, Hobbins JC, Mahoney MJ, Naftolin F. Yolk sac failure in embryopathy due to hyperglycemia: Horseradish peroxidase uptake in the assessment of yolk sac function. Obstet Gynecol 1989;74:755-762
31. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes 1998;47:859-866
32. Kuroki T, Inoguchi T, Umeda F, Nawata H. Effect of eicosapentaenoic acid on glucose-induced diacyl glycerol synthesis in culture bovine aortic endothelial cells. Biochem Biophys Res Commun 1998;247:473-477
33. Kunisaki M, Fumio U, Nawata H, King GL. Vitamin E normalizes diacylglycerol-protein kinase C activation induced by hyperglycemia in rat vascular tissues. Diabetes 1996;45 (Suppl 3):S117-S119
34. Hill JR, Kwon G, Marshall CA, McDaniel ML. Hyperglycemic levels of glucose inhibit interleukin 1 release from RAW 264.7 murine macrophages by activation of protein kinase C. J Biol Chem 1998;273:3308-3313
35. Ishii H, Koya D, King GL. Protein kinase C activation and its role in the development of vascular complications in diabetes mellitus. J Mol Med 1998;76:21-31
36. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL. Characterization of protein kinase C beta isoform activation on the gene expression of transforming growth factor-beta, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest 1997;100:115-126
37. Krook A, Kawano Y, Song XM, et al. Improved glucose tolerance restores insulin-stimulated Akt kinase activity and glucose transport in skeletal muscle from diabetic Goto-Kakizaki rats. Diabetes 1997;46:2110-2114
38. Staubs PA, Nelson JG, Reichart DR, Olefsky JM. Platelet-derived growth factor inhibits insulin stimulation of insulin receptor substrate-1-associated phosphatidylinositol 3-kinase in 3T3-L1 adipocytes without affecting glucose transport. J Biol Chem 1998;273:25139-25147
39. Lavan BE, Kuhne MR, Garner CW, et al. The association of insulin-elicited phosphotyrosine proteins with src homology 2 domains. J Biol Chem 1992;267:11631-11636
40. Di Guglielmo GM, Drake PG, Baass PC, Authier F, Posner BI, Bergeron JJ. Insulin receptor internalization and signalling. Mol Cell Biochem 1998;182:59-63
41. Alessi DR, Cohen P. Mechanism of activation and function of protein kinase B. Curr Opin Genet Dev 1998;8:55-62
42. Datta SR, Dudek H, Tao X, et al. Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997;91:231-241
43. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Biol 1998;10:262-267
44. Kurowski TG, Lin Y, Luo Z, et al. Hyperglycemia inhibits insulin activation of Akt/protein kinase B but not phosphatidylinositol 3-kinase in rat skeletal muscle. Diabetes 1999;48:658-663
45. Furth AJ. Glycated proteins in diabetes. Br J Biomed Sci 1997;54:192-200
46. Dhanasekaran N, Reddy EP. Signaling by dual specificity kinases. Oncogene 1998;17:1447-1455
47. Igarashi M, Wakasaki H, Takahara N, et al. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest 1999;103:185-195
48. Berra E, Diaz-Meco MT, Moscat J. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway. J Biol Chem 1998;273:10792-10797
49. Yerneni KK, Bai W, Khan BV, Medford RM, Natarajan R. Hyperglycemia-induced activation of nuclear transcription factor kappaB in vascular smooth muscle cells. Diabetes 1999;48:855-864
50. Pieper GM, Riaz-ul-Haq. Activation of nuclear factor kappaB in cultured endothelial cells by increased glucose concentration: Prevention by calphostin C. J Cardiovasc Pharmacol 1997;30:528-532
51. Nick JA, Avdi NJ, Young SK, et al. Selective activation and functional significance of p38alpha mitogen-activated protein kinase in lipopolysaccharide-stimulated neutrophils. J Clin Invest 1999;103:851-858.
52. Kim SJ, Kahn CR. Insulin regulation of mitogen-activated protein kinase kinase (MEK), mitogen-activated protein kinase and casein kinase in the cell nucleus: A possible role in the regulation of gene expression. Biochem J 1997;323:621-627
53. Avruch J. Insulin signal transduction through protein kinase cascades. Mol Cell Biochem 1998;182:31-48
54. 2 activation. J Leukoc Biol 1999;65:330-336
55. Barry OP, Kazanietz MG, Pratico D, FitzGerald GA. Cyclooxygenase-2-dependent prostaglandin formation via a protein kinaseC/mitogen-activated protein kinase dependent pathway. J Biol Chem 1999;274:7545-7556
56. Mendelson KG, Contois LR, Tevosian SG, Davis RJ, Paulson KE. Independent regulation of JNK/p38 mitogen-activated protein kinases by metabolic oxidative stress in the liver. Proc Natl Acad Sci USA 1996;93:12908-12913
57. Uchida K, Shiraishi M, Naito Y, Torii Y, Nakamura Y, Osawa T. Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J Biol Chem 1999;274:2234-2242
58. 2 superfamily of signal transduction enzymes. Trends Biochem Sci 1997;22:1-2
59. 2. J Biol Chem 1997;272:16709-16712
60. Williams CS, DuBois RN. Prostaglandin endoperoxide synthase: Why two isoforms? Am J Physiol 1996;270:G393-G400
61. Vane JR, Bakhle YS, Botting RM. Cycloxygenases 1 and 2. Annu Rev Phramacol Toxicol 1998;38:97-120
62. Reece EA, Homko CJ, Wu Y-K, Wiznitzer A. The role of free radicals and membrane lipids in diabetes-induced congenital malformations. J Soc Gynecol Invest 1998;5:178-187